These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 27761468)

  • 1. Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory.
    Romero-Aroca P; Baget-Bernaldiz M; Pareja-Rios A; Lopez-Galvez M; Navarro-Gil R; Verges R
    J Diabetes Res; 2016; 2016():2156273. PubMed ID: 27761468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and pharmacological targets of VEGF in diabetic macular edema.
    Fogli S; Mogavero S; Egan CG; Del Re M; Danesi R
    Pharmacol Res; 2016 Jan; 103():149-57. PubMed ID: 26607863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications.
    Zhang J; Zhang J; Zhang C; Zhang J; Gu L; Luo D; Qiu Q
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone.
    Brooks HL; Caballero S; Newell CK; Steinmetz RL; Watson D; Segal MS; Harrison JK; Scott EW; Grant MB
    Arch Ophthalmol; 2004 Dec; 122(12):1801-7. PubMed ID: 15596583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Choice of treatment for diabetic macular edema].
    Yang L; Zhang J
    Zhonghua Yan Ke Za Zhi; 2017 Oct; 53(10):724-728. PubMed ID: 29050184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema.
    Noma H; Yasuda K; Shimura M
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Case of Diabetic Macular Edema with Improvement in Severity of Diabetic Retinopathy following Frequent Anti-Vascular Endothelial Growth Factor Treatment].
    Yoshida S; Yamana S; Inoue R; Kubo Y; Kobayashi Y; Nakama T; Sonoda KH; Ishibashi T
    Nippon Ganka Gakkai Zasshi; 2017 May; 121(5):425-30. PubMed ID: 30074752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and investigational drugs for the treatment of diabetic retinopathy.
    Tolentino MS; Tolentino AJ; Tolentino MJ
    Expert Opin Investig Drugs; 2016 Sep; 25(9):1011-22. PubMed ID: 27367620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiology and therapeutic progress of diabetic macular edema].
    Li B; Ye JJ
    Zhonghua Yan Ke Za Zhi; 2018 Aug; 54(8):625-630. PubMed ID: 30107656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines and Growth Factors as Predictors of Response to Medical Treatment in Diabetic Macular Edema.
    Torres-Costa S; Alves Valente MC; Falcão-Reis F; Falcão M
    J Pharmacol Exp Ther; 2020 Jun; 373(3):445-452. PubMed ID: 32245883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory mediators in the vitreal reflux of patients with diabetic macular edema.
    Cacciamani A; Esposito G; Scarinci F; Parravano M; Dinice L; Di Nicola M; Micera A
    Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):187-197. PubMed ID: 30377797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Therapies in Development for Diabetic Macular Edema.
    Agarwal A; Afridi R; Hassan M; Sadiq MA; Sepah YJ; Do DV; Nguyen QD
    Curr Diab Rep; 2015 Oct; 15(10):75. PubMed ID: 26294336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-regulated protein 78 in the aqueous humor in diabetic macular edema patients.
    Kwon JW; Jung I; Jee D
    Medicine (Baltimore); 2018 Nov; 97(45):e12757. PubMed ID: 30407281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of the retinal pigment epithelium (RPE) in the pathogenesis and treatment of diabetic macular edema (DME)].
    Chmielewska K; Robaszkiewicz J; Kosatka M
    Klin Oczna; 2008; 110(7-9):318-20. PubMed ID: 19112870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic Macular Edema: Options for Adjunct Therapy.
    Calvo P; Abadia B; Ferreras A; Ruiz-Moreno O; Verdes G; Pablo LE
    Drugs; 2015 Sep; 75(13):1461-9. PubMed ID: 26242766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
    Funatsu H; Yamashita H; Sakata K; Noma H; Mimura T; Suzuki M; Eguchi S; Hori S
    Ophthalmology; 2005 May; 112(5):806-16. PubMed ID: 15878060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of soluble CD14 and cytokine levels on diabetic macular edema and visual acuity.
    Umazume K; Usui Y; Wakabayashi Y; Okunuki Y; Kezuka T; Goto H
    Retina; 2013 May; 33(5):1020-5. PubMed ID: 23095769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antivascular endothelial growth factor in diabetic retinopathy.
    Iacono P; Battaglia Parodi M; Bandello F
    Dev Ophthalmol; 2010; 46():39-53. PubMed ID: 20703031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutic targets in diabetic macular edema: Beyond VEGF.
    Urias EA; Urias GA; Monickaraj F; McGuire P; Das A
    Vision Res; 2017 Oct; 139():221-227. PubMed ID: 28993218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic macular edema.
    Lang GE
    Ophthalmologica; 2012; 227 Suppl 1():21-9. PubMed ID: 22517122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.